<html>
    <head>
        <link rel="stylesheet" type="text/css" href="../main.css">
        <script src="../header.js" type="text/javascript" defer></script>
    </head>
    <body>
        <header-component></header-component>
        <main class="review">
            <h1 class="header">Carotenoids and Cancer</h1>

            <h2>Introduction</h2>
            <p>
                Carotenoids are a broad category of hundreds<sup>1,2</sup>Â­ and perhaps thousands<sup>3</sup> of phytochemicals (plant chemicals)<sup>4</sup> that possess a long isoprene chain and 
                a beta-ionone ring at either end. The conjugated chemical bonds in this system neutralize free radicals that cause tissue damage, inflammation, and cancer pathogenesis in 
                animals<sup>5,6</sup>. These conjugated bonds also produce the characteristic colors of carotenoids: e.g. the orange of carrots (beta-carotene) and the red of tomatoes (lycopene).
            </p>
            <p>
                Carotenoids can be classified along two axes: a) the ability to be converted into vitamin A and b) the presence of an oxygen atom in the molecular structure. Common carotenoids 
                are classified along these axes in <strong>Table 1</strong>. Carotenoids that can be converted into vitamin A are "pro-vitamin A" carotenoids. These carotenoids are cleaved in 
                half by "beta-carotene-15,15'-oxygenase" enzymes <sup>7</sup> to yield vitamin A, which results in twice the vitamin A potency of beta-carotene relative to other pro-vitamin A's 
                since both halves yield vitamin A<sup>8</sup>. The vitamin A system regulates apoptosis, immune function <sup>9</sup>, the health of surface tissues (e.g. skin)<sup>10</sup>, and 
                light detection in the eyes<sup>11</sup>. Carotenoids, in the other axis, that possess an oxygen atom are xanthophylls while those that do not are carotenes. The presence of an 
                oxygen in xanthophylls doubles its bioavailability<sup>12</sup> relative to carotenes<sup>11</sup>, although, consuming carotenes with oils can equalize the bioavailability of carotenes and xanthophylls<sup>13,14</sup>.
            </p>
            <p>
                Excessive consumption of carotenoids, through food or especially supplementation, is mostly associated with two non-toxic and reversible conditions: the yellowing of skin 
                ("carotenosis") <sup>15</sup> and diminished vision. The latter is based one case of an 84-year-old woman whose vision degraded after supplementation with <sup>16</sup>; 
                however, her vision returned eighteen months after discontinuing the supplements <sup>17</sup>. The most deleterious effect of carotenoids may be its hepatotoxic interaction 
                with alcohol, similar to retinol vitamin A <sup>18</sup>. These excessive effects, however, are in stark contrast to retinol vitamin A - from animal products - which can be 
                fatal in meal dosages<sup>19-21</sup>, partly because of its high bioavailability <sup>22</sup>.
            </p>
            
            <h2>Research</h2>
            <p>
                Discriminating science from pseudo-science and misinformation is difficult for health scientists and laymen alike, where principled arguments for diets/lifestyles can be confused 
                can potentially inspire deleterious habits. The following essay demystifies a corner of nutritional science: the chemopreventive role of carotenoids. Many studies use serum 
                carotenoid concentrations to mitigate error from dietary logging and the inherent subjectivity in estimating consumption <sup>22</sup>.
            </p>
            <p>
                <strong>Breast Cancer </strong>is genetically influenced by the BRCA1 and BRCA2 genes; however, 75-95% of breast cancer cases<sup>23</sup> are attributed to lifestyle habits, 
                e.g. alcohol consumption (see <a href="https://thesustainablevegan.org/alcohol-and-cancer/">the alcohol consumption post</a>). Breast cancer risk is interestingly inversely 
                proportional with carotenoid consumption in women with BMI &lt;25 <sup>24</sup> and proportional in women with BMIs of &gt; 30<sup>25</sup>. This perplexingly observation is 
                explained by metabolic differences in obese women <sup>26</sup>.
            </p>
            <p>
                <strong>Lung Cancer </strong>risk diminished in non-smokers with high carotenoid consumption<sup>27</sup> yet not with supplementation<sup>28</sup>, which suggests that corollary 
                benefits of carotenoid-rich foods may be contributing preventative effects. Lycopene supplementation, however, diminished cancer risk<sup>27</sup>, which suggests a direct preventative effect.
            </p>
            <p>
                <strong>Prostate Cancer </strong>is significantly reduced by lycopene<sup>29,30</sup>. Lycopene specifically augments the efficacy of prostate chemotherapy drugs by ~30-107%<sup>31</sup>! 
                Animal-sourced vitamin A, by contrast, <em>increased</em> the risk of prostate cancer<sup>29</sup>.
            </p>
            <p>
                <strong>Other Cancers </strong>are diminished by carotenoid consumption as well. <em>Colorectal cancer</em> rates were inversely correlated with serum carotenoid concentrations<sup>32,33</sup>. 
                <em>Liver cancer </em>cells were killed by beta-carotene isolate on contact<sup>34</sup>.<em> Kidney cancer</em> is least frequent among people with the greatest consumption of fruits and 
                vegetables<sup>35</sup>, and specifically men who can better absorb and process carotenoids than women<sup>26</sup>. <em>Head and neck cancers</em> are ~50% fatal<sup>36</sup>; yet, fruit 
                and vegetable consumption<sup>22</sup>, specifically beta-carotene with vitamin C and fiber<sup>37</sup>, lowers the risk.
            </p>
            
            <h2>Conclusion</h2>
            <p>
                The aforementioned research suggests that the benefits of carotenoid consumption, particularly for non-drinkers, are profound in the context of diminished cancer risks. A preliminary 
                estimate of diet-induced premature deaths in the USA was 678,000 in 2010<sup>38</sup>, and accounted for &gt; 5% of all cancers<sup>39</sup> that collectively cost ~$4 billion<sup>40</sup>. 
                The implicit public health epidemic of suffering from dietary diseases has an obvious solution: eat more colorful vegetables!
            </p>

            <p class="table_header">
                <strong>Table 1</strong>: Carotenoids and food examples categorically arranged along two axes: provitamin A, and carotene vs. xanthophyll. <br> 
                The vitamin A potencies of provitamin A carotenoids are provided in parentheses relative to pure vitamin A (retinol).
            </p>
            <table>
                <tbody>
                    <tr>
                        <td><b>Vitamin-A status</b></td>
                        <td colspan="2"><strong>Carotene</strong></td>
                        <td colspan="2"><strong>Xanthophyll</strong></td>
                    </tr>
                    <tr>
                        <td></td>
                        <td><b>Chemical</b></td>
                        <td><b>Sources</b></td>
                        <td><b>Chemical</b></td>
                        <td><b>Sources</b></td>
                    </tr>
                    <tr>
                        <td rowspan="2"><strong>Yes</strong> <sup>7</sup></td>
                        <td><em>Alpha-carotene</em> (~4%)</td>
                        <td>Carrots</td>
                        <td rowspan="2"><em>Cryptoxanthins</em> (~4%)</td>
                        <td rowspan="2">Tangerines and papayas</td>
                    </tr>
                    <tr>
                        <td><em>Beta-carotene</em> (~8%)<sup>8</sup></td>
                        <td>Apricots, carrots, sweet potatoes, <br> spinach, broccoli, and butternut squash<sup>41</sup></td>
                    </tr>
                    <tr>
                        <td rowspan="2"><strong>No</strong></td>
                        <td><em>Lycopene</em></td>
                        <td>Tomatoes</td>
                        <td><em>Lutein + Zeaxanthin</em></td>
                        <td>Broccoli, spinach, kale, collard greens, <br> arugula, green peas, fennel/anise, and yellow egg yolks.</td>
                    </tr>
                    <tr>
                        <td><em>Gamma-carotene</em> (~4%)</td>
                        <td>Corn, yellow bell peppers, figs, and papaya</td>
                        <td><em>Astaxanthin</em></td>
                        <td>Algae, salmon skin</td>
                    </tr>
                </tbody>
            </table>
            <p class="table_header">
                <strong>Table 2</strong>: Cancer reduction rates of people with the greatest carotenoid consumption/retention relative to people with the lowest carotenoid consumption/retention. <br>
                Entries without data are denoted with "--", which not significant data is denoted "NS".
            </p>

            <table>
                <thead>
                  <tr>
                    <th>Chemical</th>
                    <th>Breast cancer</th>
                    <th>Lung cancer</th>
                    <th>Colorectal cancer</th>
                    <th>Prostate cancer</th>
                  </tr>
                </thead>
                <tbody>
                    <tr><td colspan="5"><b>Carotenes</b></td></tr>
                  <tr>
                    <td>Alpha-carotene</td>
                    <td>26%[24]</td>
                    <td>25%[27]</td>
                    <td>51%[32]</td>
                    <td>--</td>
                  </tr>
                  <tr>
                    <td>Beta-carotene</td>
                    <td>28%[24]</td>
                    <td>NS</td>
                    <td>NS</td>
                    <td>--</td>
                  </tr>
                  <tr>
                    <td>Lycopene</td>
                    <td>18%[24]</td>
                    <td>63%[27]</td>
                    <td>64%[32]</td>
                    <td>17-73% with chemotherapy[31]</td>
                  </tr>
                  <tr>
                    <td colspan="5"><b>Xanthophylls</b></td>
                  </tr>
                  <tr>
                    <td>Lutein</td>
                    <td>NS</td>
                    <td>NS</td>
                    <td>NS</td>
                    <td>--</td>
                  </tr>
                  <tr>
                    <td>Zeaxanthin</td>
                    <td>NS</td>
                    <td>--</td>
                    <td>NS</td>
                    <td>--</td>
                  </tr>
                  <tr>
                    <td>Beta-cryptoxanthin</td>
                    <td>BMI &lt; 25: 30%[24]</td>
                    <td>NS</td>
                    <td>56%[32]</td>
                    <td>--</td>
                  </tr>
                  <tr>
                    <td>Astaxanthin</td>
                    <td>NS</td>
                    <td>--</td>
                    <td>31%[33]</td>
                    <td>--</td>
                  </tr>
                </tbody>
            </table>

            <h2>References</h2>
            <ol class="references">
                <li>RodrÃ­guez-Bernaldo de QuirÃ³s, A. &amp; Costa, H. S. Analysis of carotenoids in vegetable and plasma samples: A review. <em>J. Food Compos. Anal.</em> <strong>19</strong>, 97-111 (2006).</li>
                <li>Dagatti, M. S. <em>et al.</em> Protective effect of macro and micro nutrients on male lung cancer. A case-control study in Rosario, Argentina. <em>e-SPEN</em> <strong>4</strong>, (2009).</li>
                <li>Yabuzaki, J. Carotenoids Database: Structures, chemical fingerprints and distribution among organisms. <em>Database</em> <strong>2017</strong>, 1-11 (2017).</li>
                <li>Kaulmann, A. &amp; Bohn, T. Carotenoids, inflammation, and oxidative stress-implications of cellular signaling pathways and relation to chronic disease prevention. <em>Nutr. Res.</em> <strong>34</strong>, 907-929 (2014).</li>
                <li>Tanaka, T. <em>et al.</em> A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. <em>Cancer Sci.</em> <strong>94</strong>, 965-973 (2003).</li>
                <li>MartÃ­nez-SÃ¡nchez, G. &amp; Giuliani, A. Cellular redox status regulates hypoxia inducible factor-1 activity. Role in tumour development. <em>J. Exp. Clin. Cancer Res.</em> <strong>26</strong>, 39-50 (2007).</li>
                <li>Giuliano, G., Al-Babili, S. &amp; Lintig, J. von. Carotenoid oxygenases: cleave it or leave it. <em>Trends Plant Sci.</em> <strong>8</strong>, 143-145 (2003).</li>
                <li>Simpson, K. L. Relative value of carotenoids as precursors of vitamin A. <em>Proc. Nutr. Soc.</em> <strong>42</strong>, 7-17 (1983).</li>
                <li>Korichneva, I. &amp; HÃ¤mmerling, U. F-actin as a functional target for retro-retinoids: A potential role in anhydroretinol-triggered cell death. <em>J. Cell Sci.</em> <strong>112</strong>, 2521-2528 (1999).</li>
                <li>Carolyn D. Berdanier, L. A. B. <em>Advanced Nutrition: Macronutrients, Micronutrients, and Metabolism</em>. (CRC Press, 2021).</li>
                <li>McGuire, M. &amp; Beerman, K. A. <em>Nutritional Sciences: From Fundamentals to Food</em>. (Cengage Learning, 2022).</li>
                <li>Huo, T., Ferruzzi, M. G., Schwartz, S. J. &amp; Failla, M. L. Impact of fatty acyl composition and quantity of triglycerides on bioaccessibility of dietary carotenoids. <em>Journal of Agricultural and Food Chemistry</em> vol. 55 8950-8957 (2007).</li>
                <li>Knockaert, G., Lemmens, L., Van Buggenhout, S., Hendrickx, M. &amp; Van Loey, A. Changes in Î²-carotene bioaccessibility and concentration during processing of carrot puree. <em>Food Chem.</em> <strong>133</strong>, 60-67 (2012).</li>
                <li>Verkempinck, S. H. E. <em>et al.</em> Kinetic approach to study the relation between in vitro lipid digestion and carotenoid bioaccessibility in emulsions with different oil unsaturation degree. <em>J. Funct. Foods</em> <strong>41</strong>, 135-147 (2018).</li>
                <li>Granado-Lorencio, F., Blanco-Navarro, I., PÃ©rez-SacristÃ¡n, B. &amp; HernÃ¡ndez-Ãlvarez, E. Biomarkers of carotenoid bioavailability. <em>Food Res. Int.</em> <strong>99</strong>, 902-916 (2017).</li>
                <li>Beaulieu, R. A., Warwar, R. E. &amp; Buerk, B. M. Canthaxanthin Retinopathy with Visual Loss: A Case Report and Review. <em>Case Rep. Ophthalmol. Med.</em> <strong>2013</strong>, 1-4 (2013).</li>
                <li>Hueber, A., Rosentreter, A. &amp; Severin, M. Canthaxanthin retinopathy: Long-term observations. <em>Ophthalmic Res.</em> <strong>46</strong>, 103-106 (2011).</li>
                <li>Leo, M. A. &amp; Lieber, C. S. Alcohol, vitamin A, and Î²-carotene: Adverse interactions, including hepatotoxicity and carcinogenicity. <em>Am. J. Clin. Nutr.</em> <strong>69</strong>, 1071-1085 (1999).</li>
                <li>Myhre, A. M. <em>et al.</em> Water-miscible, emulsified, and solid forms of retinol supplements are more toxic than oil-based preparations. <em>Am. J. Clin. Nutr.</em> <strong>78</strong>, 1152-1159 (2003).</li>
                <li>Leo, M. A. &amp; Lieber, C. S. Alcohol and vitamin A. <em>Gale Acad. OneFile</em> <strong>13</strong>, 250+ (1989).</li>
                <li>Carpenter, T. O. <em>et al.</em> Severe hypervitaminosis A in siblings: Evidence of variable tolerance to retinol intake. <em>J. Pediatr.</em> <strong>111</strong>, 507-512 (1987).</li>
                <li>Sivakumar, B. &amp; Reddy, V. Absorption of labelled vitamin A in children during infection. <em>Br. J. Nutr.</em> <strong>27</strong>, 299-304 (1972).</li>
                <li>Cartmel, B., Bowen, D., Ross, D., Johnson, E. &amp; Mayne, S. T. A randomized trial of an intervention to increase fruit and vegetable intake in curatively treated patients with early-stage head and neck cancer. <em>Cancer Epidemiol. Biomarkers Prev.</em> <strong>14</strong>, 2848-2854 (2005).</li>
                <li>Miki, Y. <em>et al.</em> A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. <em>Science (80-. ).</em> <strong>266</strong>, 66-71 (1994).</li>
                <li>Eliassen, A. H. <em>et al.</em> Plasma carotenoids and risk of breast cancer over 20 y of follow-up. <em>Am. J. Clin. Nutr.</em> <strong>101</strong>, 1197-1205 (2015).</li>
                <li>Eliassen, A. H. <em>et al.</em> Circulating carotenoids and risk of breast cancer: Pooled analysis of eight prospective studies. <em>J. Natl. Cancer Inst.</em> <strong>104</strong>, 1905-1916 (2012).</li>
                <li>Tang, G., Qin, J., Dolnikowski, G. G. &amp; Russell, R. M. Short-term (intestinal) and long-term (postintestinal) conversion of beta-carotene to retinol in adults as assessed by a stable-isotope reference method. <em>Am. J. Clin. Nutr.</em> <strong>78</strong>, 259-266 (2003).</li>
                <li>Michaud, D. S. <em>et al.</em> Intake of specific carotenoids and risk of lung cancer in 2 prospective US cohorts. <em>Am. J. Clin. Nutr.</em> <strong>72</strong>, 990-997 (2000).</li>
                <li>Gallicchio, L. <em>et al.</em> Carotenoids and the risk of developing lung cancer: A systematic review. <em>Am. J. Clin. Nutr.</em> <strong>88</strong>, 372-383 (2008).</li>
                <li>Giovannucci, E. <em>et al.</em> Alcohol, low-methionine-low-folate diets, and risk of colon cancer in men. <em>J. Natl. Cancer Inst.</em> <strong>87</strong>, 265-273 (1995).</li>
                <li>Van Hoang, D., Pham, N. M., Lee, A. H., Tran, D. N. &amp; Binns, C. W. Dietary carotenoid intakes and prostate cancer risk: A case-control study from Vietnam. <em>Nutrients</em> vol. 10 (2018).</li>
                <li>Rafi, M. M., Kanakasabai, S., Reyes, M. D. &amp; Bright, J. J. Lycopene modulates growth and survival associated genes in prostate cancer. <em>J. Nutr. Biochem.</em> <strong>24</strong>, 1724-1734 (2013).</li>
                <li>Huang, J. <em>et al.</em> Serum carotenoids and colorectal cancer risk: A case-control study in Guangdong, China. <em>Mol. Nutr. Food Res.</em> <strong>61</strong>, (2017).</li>
                <li>Yasui, Y., Hosokawa, M., Mikami, N., Miyashita, K. &amp; Tanaka, T. Dietary astaxanthin inhibits colitis and colitis-associated colon carcinogenesis in mice via modulation of the inflammatory cytokines. <em>Chem. Biol. Interact.</em> <strong>193</strong>, 79-87 (2011).</li>
                <li>Kavalappa, Y. P. <em>et al.</em> Î²-carotene isolated from the marine red alga, Gracillaria sp. potently attenuates the growth of human hepatocellular carcinoma (HepG2) cells by modulating multiple molecular pathways. <em>J. Funct. Foods</em> <strong>52</strong>, 165-176 (2019).</li>
                <li>Lee, J. E. <em>et al.</em> Intakes of fruits, vegetables, vitamins A, C, and E, and carotenoids and risk of renal cell cancer. <em>Cancer Epidemiol. Biomarkers Prev.</em> <strong>15</strong>, 2445-2452 (2006).</li>
                <li>Chang, H. P., Sheen, L. Y. &amp; Lei, Y. P. The protective role of carotenoids and polyphenols in patients with head and neck cancer. <em>J. Chinese Med. Assoc.</em> <strong>78</strong>, 89-95 (2015).</li>
                <li>Kune, G. A. <em>et al.</em> Oral and Pharyngeal Cancer, Diet, Smoking, Alcohol, and Serum Vitamin A and Ã-Carotene Levels: A Case-Control Study in Men. <em>Nutr. Cancer</em> <strong>20</strong>, 61-70 (1993).</li>
                <li>Benjamin, E. J. <em>et al.</em> <em>Heart Disease and Stroke Statistics'2017 Update: A Report from the American Heart Association</em>. <em>Circulation</em> vol. 135 (2017).</li>
                <li>Zhang, F. F. <em>et al.</em> Preventable Cancer Burden Associated With Poor Diet in the United States. <em>JNCI Cancer Spectr.</em> <strong>3</strong>, 1-9 (2019).</li>
                <li>Chang, S. <em>et al.</em> Estimating the cost of cancer: Results on the basis of claims data analyses for cancer patients diagnosed with seven types of cancer during 1999 to 2000. <em>J. Clin. Oncol.</em> <strong>22</strong>, 3524-3530 (2004).</li>
                <li>Rao, A. V. &amp; Rao, L. G. Carotenoids and human health. <em>Pharmacol. Res.</em> <strong>55</strong>, 207-216 (2007).</li>
            </ol>
        </main>
    </body>
</html>
